Kristen Heristchi
Medical · Lakeland, FLNPI 1821072190
Payments from drug & device makers
Across 562 payments — averaging $17.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$1K
- Alkermes, Inc.$1K
- Otsuka America Pharmaceutical, Inc.$978
- Teva Pharmaceuticals USA, Inc.$761
- Axsome Therapeutics, Inc.$667
- plus $4K from 24 others
What the payments were for
- Food & beverage$9,99499%
- Education$621%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 136 | $2,030 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 68 | $1,046 |
| Alkermes, Inc. | 49 | $1,005 |
| Otsuka America Pharmaceutical, Inc. | 50 | $978 |
| Teva Pharmaceuticals USA, Inc. | 44 | $761 |
| Axsome Therapeutics, Inc. | 32 | $667 |
| Indivior Inc. | 21 | $452 |
| Neurocrine Biosciences, Inc. | 18 | $373 |
| Braeburn Inc. | 13 | $294 |
| Takeda Pharmaceuticals U.S.A., Inc. | 23 | $289 |
| Lundbeck LLC | 9 | $226 |
| Supernus Pharmaceuticals, Inc. | 10 | $206 |
| Johnson & Johnson | 6 | $192 |
| Almatica Pharma LLC | 10 | $191 |
| Vanda Pharmaceuticals Inc. | 7 | $178 |
| E.r. Squibb & Sons, L.L.C. | 8 | $174 |
| Sunovion Pharmaceuticals Inc. | 6 | $138 |
| Tempus AI, Inc | 9 | $133 |
| AstraZeneca | 8 | $132 |
| Novo Nordisk | 10 | $130 |
| Lilly USA, LLC | 7 | $111 |
| Dexcom, Inc. | 6 | $98 |
| Noven Therapeutics, LLC | 3 | $67 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $50 |
| Avanir Pharmaceuticals, Inc. | 1 | $35 |
| Idorsia Pharmaceuticals US Inc | 2 | $28 |
| Corium, LLC | 1 | $23 |
| Pfizer | 1 | $16 |
| Vertical Pharmaceuticals, LLC | 1 | $16 |
| Abbott | 1 | $16 |
How this compares
$10,056 in reported general payments places this provider in the 90th percentile of 2,031 medical providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| VraylarCariprazine Hcl | 21 | $28,546 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 68 | $8,028 |
| Gabapentin | 25 | $289 |
| Fluoxetine Hcl | 16 | $112 |
| Sertraline Hcl | 20 | $89 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieVraylar | $2,030 | $28,54621 claims |
| Almatica Pharma LLCSertraline Hcl | $191 | $8920 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,031 medical providers in Florida.
Other medical in Lakeland
- Jamie DurchinLakeland$69K
- Gary RubinRockledge$2.1M
- Shanna MirantiNaples$415K
- Krystie LennoxBoca Raton$245K
- Jihan RamadanWellington$238K
- Ilanit SamuelsMiami$211K
- Erin DouceyWinter Haven$202K
- Kathleen TrummerWellington$166K
- Sandra SnyderTampa$156K
- Francine PhillipsLand O Lakes$145K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.